SCHEMBL20965348

SCHEMBL20965348

CCC(CC)c1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.55
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.49
GAA P10253 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 2/20 0.48
RAB9A P51151 1/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
LMNA P02545 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PKM P14618 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL783991 0.91 MAPK1 (0.50) MAPK1KMT2AMEN1L3MBTL1GAA
Hydrochloric Acid SCHEMBL783922 0.90 MAPK1 (0.49) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL21725467 0.88 MAPK1 (0.48) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL20964536 0.86 MAPK1 (0.46) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL10192289 0.85 KMT2A (0.56) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL26464607 0.84 MAPK1 (0.50) MAPK1KMT2AMEN1L3MBTL1GAA
Ammonia Solution, Strong SCHEMBL27649570 0.84 KMT2A (0.55) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL6026553 0.83 MAPK1 (0.55) MAPK1KMT2AMEN1L3MBTL1GAA
Hydrochloric Acid SCHEMBL27649600 0.83 KMT2A (0.53) MAPK1KMT2AMEN1L3MBTL1GAA
SCHEMBL9967732 0.81 KMT2A (0.61) MAPK1KMT2AMEN1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127361-A1 Therapeutic Compounds RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127361-A1 Therapeutic Compounds SDHA, SLC10A1, SERPINC1 MAPK1 2069/4885KMT2A 4728/4885MEN1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.